骨关节炎与代谢综合征的关系
The Relationship between Osteoarthritis and Metabolic Syndrome
DOI: 10.12677/acm.2025.1561773, PDF,    科研立项经费支持
作者: 肖丽萍, 阎 芳*：山东第一医科大学附属省立医院疼痛科，山东 济南；李晓彤：山东第一医科大学附属省立医院麻醉科，山东 济南；汪 澍：聊城市人民医院麻醉科，山东 聊城
关键词: 骨关节炎；代谢综合征；发病机制；相互关系；临床研究；Osteoarthritis； Metabolic Syndrome； Pathogenesis； Interrelationship； Clinical Research
摘要: 本文综述了骨关节炎(Osteoarthritis, OA)与代谢综合征(Metabolic Syndrome, MetS)之间的关系，探讨了两者在发病机制、临床表现、相互影响及防治策略上的联系。研究背景部分详细介绍了OA和MetS的定义、流行病学特征及主要危险因素。研究意义部分强调了理解OA与MetS之间复杂关系的重要性，为临床治疗和公共卫生策略提供了理论依据。国内外研究现状部分通过引用大量文献，总结了当前关于OA与MetS相互关系的最新研究成果，包括流行病学证据、发病机制、临床特征及干预措施。
Abstract: This article reviews the relationship between osteoarthritis (OA) and metabolic syndrome (MetS), exploring their connections in terms of pathogenesis, clinical manifestations, mutual influences, and prevention and treatment strategies. The research background section provides a detailed introduction to the definitions, epidemiological characteristics, and major risk factors of OA and MetS. The significance of the research emphasizes the importance of understanding the complex relationship between OA and MetS, offering a theoretical foundation for clinical treatment and public health strategies. The current research status, both domestically and internationally, summarizes the latest findings on the interrelationship between OA and MetS by citing numerous references, including epidemiological evidence, pathogenic mechanisms, clinical features, and intervention measures.
文章引用：肖丽萍, 李晓彤, 汪澍, 阎芳. 骨关节炎与代谢综合征的关系[J]. 临床医学进展, 2025, 15(6): 655-662. https://doi.org/10.12677/acm.2025.1561773

参考文献

[1] Bruyère, O., Cooper, C., Arden, N., Branco, J., Brandi, M.L., Herrero-Beaumont, G., et al. (2015) Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis. Drugs & Aging, 32, 179-187. [Google Scholar] [CrossRef] [PubMed]
[2] Courties, A., Sellam, J. and Berenbaum, F. (2017) Metabolic Syndrome-Associated Osteoarthritis. Current Opinion in Rheumatology, 29, 214-222. [Google Scholar] [CrossRef] [PubMed]
[3] Deveza, L.A. and Loeser, R.F. (2017) Is Osteoarthritis One Disease or a Collection of Many? Rheumatology, 57, iv34-iv42. [Google Scholar] [CrossRef] [PubMed]
[4] Bhattacharjee, M., Escobar Ivirico, J.L., Kan, H., Shah, S., Otsuka, T., Bordett, R., et al. (2022) Injectable Amnion Hydrogel-Mediated Delivery of Adipose-Derived Stem Cells for Osteoarthritis Treatment. Proceedings of the National Academy of Sciences, 119, e2120968119. [Google Scholar] [CrossRef] [PubMed]
[5] Chen, Y., Cheng, R., Wu, Y., Huang, D., Li, Y. and Liu, Y. (2023) Advances in Stem Cell-Based Therapies in the Treatment of Osteoarthritis. International Journal of Molecular Sciences, 25, Article 394. [Google Scholar] [CrossRef] [PubMed]
[6] Thoene, M., Bejer-Olenska, E. and Wojtkiewicz, J. (2023) The Current State of Osteoarthritis Treatment Options Using Stem Cells for Regenerative Therapy: A Review. International Journal of Molecular Sciences, 24, Article 8925. [Google Scholar] [CrossRef] [PubMed]
[7] Katz, J.N., Arant, K.R. and Loeser, R.F. (2021) Diagnosis and Treatment of Hip and Knee Osteoarthritis. JAMA, 325, 568-578. [Google Scholar] [CrossRef] [PubMed]
[8] Saklayen, M.G. (2018) The Global Epidemic of the Metabolic Syndrome. Current Hypertension Reports, 20, Article No. 12. [Google Scholar] [CrossRef] [PubMed]
[9] Noubiap, J.J., Nansseu, J.R., Lontchi-Yimagou, E., Nkeck, J.R., Nyaga, U.F., Ngouo, A.T., et al. (2022) Global, Regional, and Country Estimates of Metabolic Syndrome Burden in Children and Adolescents in 2020: A Systematic Review and Modelling Analysis. The Lancet Child & Adolescent Health, 6, 158-170. [Google Scholar] [CrossRef] [PubMed]
[10] Fahed, G., Aoun, L., Bou Zerdan, M., Allam, S., Bou Zerdan, M., Bouferraa, Y., et al. (2022) Metabolic Syndrome: Updates on Pathophysiology and Management in 2021. International Journal of Molecular Sciences, 23, Article 786. [Google Scholar] [CrossRef] [PubMed]
[11] Li, D., Li, Y., Yang, S., Lu, J., Jin, X. and Wu, M. (2022) Diet-Gut Microbiota-Epigenetics in Metabolic Diseases: From Mechanisms to Therapeutics. Biomedicine & Pharmacotherapy, 153, Article 113290. [Google Scholar] [CrossRef] [PubMed]
[12] Rochester, J.R. (2013) Bisphenol A and Human Health: A Review of the Literature. Reproductive Toxicology, 42, 132-155. [Google Scholar] [CrossRef] [PubMed]
[13] Engin, A. (2024) Adiponectin Resistance in Obesity: Adiponectin Leptin/Insulin Interaction. In: Engin, A.B. and Engin, A., Eds., Advances in Experimental Medicine and Biology, Springer International Publishing, 431-462. [Google Scholar] [CrossRef] [PubMed]
[14] Sharma, A.M. and Chetty, V.T. (2005) Obesity, Hypertension and Insulin Resistance. Acta Diabetologica, 42, s3-s8. [Google Scholar] [CrossRef] [PubMed]
[15] Xiang, Q., Tian, F., Xu, J., Du, X., Zhang, S. and Liu, L. (2022) New Insight into Dyslipidemia‐Induced Cellular Senescence in Atherosclerosis. Biological Reviews, 97, 1844-1867. [Google Scholar] [CrossRef] [PubMed]
[16] Abdu, F.A., Mohammed, A., Liu, L., Yin, G., Xu, S., Mohammed, A.A., et al. (2022) Metabolic Syndrome and the Risk of Adverse Cardiovascular Events in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries. Nutrition, Metabolism and Cardiovascular Diseases, 32, 666-674. [Google Scholar] [CrossRef] [PubMed]
[17] Hu, Y., Liang, Y., Li, J., Li, X., Yu, M. and Cui, W. (2025) Correlation between Atherogenic Index of Plasma and Cardiovascular Disease Risk across Cardiovascular-Kidney-Metabolic Syndrome Stages 0-3: A Nationwide Prospective Cohort Study. Cardiovascular Diabetology, 24, Article No. 40. [Google Scholar] [CrossRef] [PubMed]
[18] Gantenbein, K.V. and Kanaka-Gantenbein, C. (2021) Mediterranean Diet as an Antioxidant: The Impact on Metabolic Health and Overall Wellbeing. Nutrients, 13, Article 1951. [Google Scholar] [CrossRef] [PubMed]
[19] Nauck, M.A., Quast, D.R., Wefers, J. and Meier, J.J. (2021) GLP-1 Receptor Agonists in the Treatment of Type 2 Diabetes—State-of-the-Art. Molecular Metabolism, 46, Article 101102. [Google Scholar] [CrossRef] [PubMed]
[20] O’Kane, M., Parretti, H.M., Pinkney, J., Welbourn, R., Hughes, C.A., Mok, J., et al. (2020) British Obesity and Metabolic Surgery Society Guidelines on Perioperative and Postoperative Biochemical Monitoring and Micronutrient Replacement for Patients Undergoing Bariatric Surgery—2020 Update. Obesity Reviews, 21, e13087. [Google Scholar] [CrossRef] [PubMed]
[21] Culliford, D., Maskell, J., Judge, A., Cooper, C., Prieto-Alhambra, D. and Arden, N.K. (2015) Future Projections of Total Hip and Knee Arthroplasty in the UK: Results from the UK Clinical Practice Research Datalink. Osteoarthritis and Cartilage, 23, 594-600. [Google Scholar] [CrossRef] [PubMed]
[22] Sharif, B., Kopec, J.A., Wong, H. and Anis, A.H. (2017) Distribution and Drivers of Average Direct Cost of Osteoarthritis in Canada from 2003 to 2010. Arthritis Care & Research, 69, 243-251. [Google Scholar] [CrossRef] [PubMed]
[23] Piché, M.-E., Tchernof, A. and Després, J.-P. (2020) Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circulation Research, 126, 1477-1500. [Google Scholar] [CrossRef] 
[24] Boutari, C., Demarsilis, A. and Mantzoros, C.S. (2023) Obesity and Diabetes. Diabetes Research and Clinical Practice, 202, Article ID: 110773. [Google Scholar] [CrossRef] [PubMed]
[25] Phillips, C.M. (2013) Metabolically Healthy Obesity: Definitions, Determinants and Clinical Implications. Reviews in Endocrine & Metabolic Disorders, 14, 219-227. [Google Scholar] [CrossRef] [PubMed]
[26] Stefan, N., Häring, H., Hu, F.B. and Schulze, M.B. (2013) Metabolically Healthy Obesity: Epidemiology, Mechanisms, and Clinical Implications. The Lancet Diabetes & Endocrinology, 1, 152-162. [Google Scholar] [CrossRef] [PubMed]
[27] Samocha‐Bonet, D., Dixit, V.D., Kahn, C.R., Leibel, R.L., Lin, X., Nieuwdorp, M., et al. (2014) Metabolically Healthy and Unhealthy Obese—The 2013 stock conference Report. Obesity Reviews, 15, 697-708. [Google Scholar] [CrossRef] [PubMed]
[28] Jung, C.H., Lee, W.J. and Song, K. (2017) Metabolically Healthy Obesity: A Friend or Foe? The Korean Journal of Internal Medicine, 32, 611-621. [Google Scholar] [CrossRef] [PubMed]
[29] Engström, G., Gerhardsson de Verdier, M., Rollof, J., Nilsson, P.M. and Lohmander, L.S. (2009) C-Reactive Protein, Metabolic Syndrome and Incidence of Severe Hip and Knee Osteoarthritis. A Population-Based Cohort Study. Osteoarthritis and Cartilage, 17, 168-173. [Google Scholar] [CrossRef] [PubMed]
[30] Gandhi, R., Razak, F., Tso, P., Davey, J.R. and Mahomed, N.N. (2010) Asian Ethnicity and the Prevalence of Metabolic Syndrome in the Osteoarthritic Total Knee Arthroplasty Population. The Journal of Arthroplasty, 25, 416-419. [Google Scholar] [CrossRef] [PubMed]
[31] 项坤三, 纪立农, 向红丁, 等. 中华医学会糖尿病学分会关于代谢综合征的建议[J]. 中华糖尿病杂志, 2004, 12(3): 156-161.
[32] Wei, G., Lu, K., Umar, M., Zhu, Z., Lu, W.W., Speakman, J.R., et al. (2023) Risk of Metabolic Abnormalities in Osteoarthritis: A New Perspective to Understand Its Pathological Mechanisms. Bone Research, 11, Article No. 63. https://doi.org/10.1038/s41413-023-00301-9
[33] Nedunchezhiyan, U., Varughese, I., Sun, A.R., Wu, X., Crawford, R. and Prasadam, I. (2022) Obesity, Inflammation, and Immune System in Osteoarthritis. Frontiers in Immunology, 13, Article 907750. [Google Scholar] [CrossRef] [PubMed]
[34] Murdolo, G., Bartolini, D., Tortoioli, C., Piroddi, M., Iuliano, L. and Galli, F. (2013) Lipokines and Oxysterols: Novel Adipose-Derived Lipid Hormones Linking Adipose Dysfunction and Insulin Resistance. Free Radical Biology and Medicine, 65, 811-820. [Google Scholar] [CrossRef] [PubMed]
[35] Shimano, H. (2012) Novel Qualitative Aspects of Tissue Fatty Acids Related to Metabolic Regulation: Lessons from Elovl6 Knockout. Progress in Lipid Research, 51, 267-271. [Google Scholar] [CrossRef] [PubMed]
[36] Tsezou, A., Iliopoulos, D., Malizos, K.N. and Simopoulou, T. (2010) Impaired Expression of Genes Regulating Cholesterol Efflux in Human Osteoarthritic Chondrocytes. Journal of Orthopaedic Research, 28, 1033-1039. [Google Scholar] [CrossRef] [PubMed]
[37] Sampath, S.J.P., Venkatesan, V., Ghosh, S. and Kotikalapudi, N. (2023) Obesity, Metabolic Syndrome, and Osteoarthritis—An Updated Review. Current Obesity Reports, 12, 308-331. [Google Scholar] [CrossRef] [PubMed]
[38] Iannone, F. and Lapadula, G. (2010) Obesity and Inflammation—Targets for OA Therapy. Current Drug Targets, 11, 586-598. [Google Scholar] [CrossRef] [PubMed]
[39] 栗占国. 骨关节炎诊治指南(草案) [J]. 中华风湿病学杂志, 2003, 7(11): 702-704.
[40] 韦阁. 炎性细胞因子及代谢综合征在骨性关节炎发病机制中的研究现状[J]. 中国社区医师, 2019, 35(16): 9-10.
[41] Ledford, C.K., Elstad, Z.M., Fruth, K.M., Wilke, B.K., Pagnano, M.W., Berry, D.J., et al. (2022) The Impact of Metabolic Syndrome on Reoperations and Complications after Primary Total Hip Arthroplasty. The Journal of Arthroplasty, 37, 1092-1097. [Google Scholar] [CrossRef] [PubMed]
[42] 张新颖, 钱秋海. 代谢综合征中西医诊疗现状与展望[J]. 中国临床保健杂志, 2023, 26(5): 600-605.
[43] 舒祥兵, 操颖, 顾晔, 杨志新, 季光, 张莉. 强肝胶囊促进肝糖原合成降低大鼠高血糖的机制研究[J]. 上海中医药大学学报, 2021, 35(3): 45-51.
[44] Zhu, L., Kamalathevan, P., Koneva, L.A., Zarebska, J.M., Chanalaris, A., Ismail, H., et al. (2022) Variants in ALDH1A2 Reveal an Anti-Inflammatory Role for Retinoic Acid and a New Class of Disease-Modifying Drugs in Osteoarthritis. Science Translational Medicine, 14, 40-54. [Google Scholar] [CrossRef] [PubMed]
[45] Liang, Y., Shen, L., Ni, W., Ding, Y., Yang, W., Gu, T., et al. (2023) CircGNB1 Drives Osteoarthritis Pathogenesis by Inducing Oxidative Stress in Chondrocytes. Clinical and Translational Medicine, 13, e1358. [Google Scholar] [CrossRef] [PubMed]
[46] Liao, S., Zheng, Q., Shen, H., Yang, G., Xu, Y., Zhang, X., et al. (2023) HECTD1‐Mediated Ubiquitination and Degradation of Rubicon Regulates Autophagy and Osteoarthritis Pathogenesis. Arthritis & Rheumatology, 75, 387-400. [Google Scholar] [CrossRef] [PubMed]

为你推荐